Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

T-900607, a novel tubulin-binding agent, on track for clinical development

April 4, 2000

Simplified halichondrin B analogues retain potent anticancer activity

April 4, 2000

SB-238039: a new antitumor agent that appears to act as a Jak2 inhibitor

April 4, 2000

Novel inhibitors of cyclin-dependent kinases discovered by Korean researchers

April 4, 2000

EntreMed commences phase I clinical trial of 2-methoxyestradiol

April 4, 2000

ImClone Systems awarded SBIR grant for antiangiogenesis research

April 4, 2000

Apoptosis induced in human leukemia cells by topoisomerase I inhibitor BN-80915

April 3, 2000

AACR highlights: selective PDGF receptor antagonist effectively reduces tumor growth in vivo

April 3, 2000

Pharmacokinetics, toxicity, biological activity of COL-3 in cancer patients

April 3, 2000

BMS-275291 inhibits angiogenesis and/or tumor metastasis in vivo and in early clinical trial

April 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...